Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants.

British journal of cancer - 1 Oct 2023

Yang Yaohua, Xu Shuai, Jia Guochong, Yuan Fangcheng, Ping Jie, Guo Xingyi, Tao Ran, Shu Xiao-Ou, Zheng Wei, Long Jirong, Cai Qiuyin

Abstract excerpt

BACKGROUND: Plasma proteins are potential biomarkers for complex diseases. We aimed to identify plasma protein biomarkers for lung cancer. METHODS: We investigated genetically predicted plasma levels of 1130 proteins in association with lung cancer risk among 29,266 cases and 56,450 controls of European descent. For proteins significantly associated with lung cancer risk, we evaluated associations of genetically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Proteins

Share to Genetic Predisposition to Disease

Share to Genome-Wide Association Study

Share to Lung Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Proteomics

Source

Open in PubMed Open full text

Identifiers

PMID: 37679517
DOI: 10.1038/s41416-023-02419-3
PMCID: PMC10628278

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants.PMID 37679517Read ↗

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancerSemantic proximity Read ↗

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity Read ↗

Integration of lung tissue proteomics and genome-wide association data to identify lung cancer susceptibility proteins and potential drug targetsSemantic proximity Read ↗

Identification of promising lung cancer drug targets from human plasma proteins: Mendelian randomization, single-cell RNA sequencing analysisSemantic proximity Read ↗

Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.Semantic proximity Read ↗

IL-18 and Lower Risk for Lung Cancer: Triangulated Evidence from Germline Predictions, Pre-Diagnostic Measurements, and Tumor ExpressionSemantic proximity Read ↗

Identification of novel pQTL-SNPs associated with lung adenocarcinoma risk: A multi-stage study.Semantic proximity Read ↗

Exploration of plasma genetic markers mediating lung cancer-induced cardiovascular disorders based on genome wide association studies.Semantic proximity Read ↗

Fine-mapping the MHC region in Asian populations identified novel variants modifying susceptibility to lung cancer.Semantic proximity Read ↗

Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung CancerSemantic proximity Read ↗

Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.Semantic proximity Read ↗

Genetically predicted circulating protein biomarkers and ovarian cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.